Primary Endpoint
Also known as: Primary outcome, Primary efficacy endpoint, Main endpoint
Primary Endpoint is the main outcome measure in a clinical trial that directly addresses the study's primary objective and is used to determine whether the intervention is effective. The primary endpoint is specified before the trial begins and drives sample size calculations and regulatory decisions.
Last updated: January 28, 2026
How Primary Endpoints Work
Role in Trial Design
| Aspect | Primary Endpoint Function |
|---|---|
| Focus | Defines the main question |
| Sample size | Calculated to detect this outcome |
| Statistical power | Trial powered for this endpoint |
| Regulatory basis | FDA approval decision driver |
| Success criteria | Pre-specified threshold |
Primary vs Secondary Endpoints
| Type | Role | Example |
|---|---|---|
| Primary | Main outcome, drives conclusions | Weight loss % at 68 weeks |
| Secondary | Supporting outcomes | Quality of life, blood pressure |
| Exploratory | Hypothesis-generating | Subgroup analyses |
| Safety | Adverse event monitoring | GI side effects, cardiovascular |
Relevance to Peptides
Primary Endpoints in Major Peptide Trials
STEP 1 (Semaglutide - Obesity)
- Primary endpoint: Percent change in body weight at 68 weeks
- Result: -14.9% (semaglutide) vs -2.4% (placebo)
- Met with high statistical significance
SURMOUNT-1 (Tirzepatide - Obesity)
- Co-primary endpoints:
- Percent change in body weight
- Participants achieving >=5% weight loss
- Both met decisively
SURPASS-2 (Tirzepatide - Diabetes)
- Primary endpoint: A1C change from baseline at 40 weeks
- Result: Superior to semaglutide 1mg
- Established efficacy for diabetes
How Endpoints Are Chosen
| Consideration | Example |
|---|---|
| Clinical relevance | Weight loss matters to patients |
| Measurability | Objective scale measurement |
| Achievability | Detectable within study duration |
| Regulatory acceptance | FDA-agreed endpoint |
| Meaningful threshold | Clinically significant change |
Statistical Considerations
Pre-Specification
- Primary endpoint defined in protocol
- Analysis plan written before unblinding
- Prevents post-hoc endpoint selection
- Ensures scientific integrity
Multiple Primary Endpoints
Some trials have co-primary endpoints:
- Both must be met for success
- Or either can be met (with adjustment)
- Increases complexity and sample size
Hierarchical Testing
Secondary endpoints tested only if primary is met:
- Primary endpoint tested first
- If significant, test first secondary
- Continue in pre-specified order
- Stops at first non-significant result
Reading Trial Results
What to Look For
| Element | Meaning |
|---|---|
| Effect size | Magnitude of difference |
| Confidence interval | Precision of estimate |
| P-value | Statistical significance |
| Clinical significance | Is the effect meaningful? |
Example Interpretation
“Mean weight loss was 15% in the treatment group vs 2% in the placebo group (difference: 13 percentage points; 95% CI: 11-15; punder 0.001)”
- Effect size: 13 percentage points
- Confidence interval: Narrow, precise
- P-value: Highly significant
- Clinical significance: Meaningful weight loss
Frequently Asked Questions
Why can’t researchers just use whatever outcome looks best?
Pre-specifying endpoints prevents cherry-picking. If researchers could choose after seeing results, they might report only favorable outcomes, misleading providers and patients. Pre-specification ensures honest reporting of whether the drug achieved its intended goal.
What if the primary endpoint fails but secondary endpoints succeed?
The trial is typically considered negative for its main objective. Secondary successes may suggest future research directions but cannot support regulatory approval for the primary indication. Some trials have been redesigned after primary endpoint failures.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.